The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms
The soluble 329 Env protein could serve as an antigenic bait, and multimeric 329 NP Envs are potential vaccine candidates.
Authors
- Sanjeev Kumar (ORCID: https://orcid.org/0000-0002-8181-3999)
- Anamika Patel (ORCID: https://orcid.org/0000-0003-4760-9019)
- Maddy L. Newby (ORCID: https://orcid.org/0000-0003-0624-245X)
- Eric A. Ortlund (ORCID: https://orcid.org/0000-0001-8855-3029)
- Tom P. L. Bijl
- Iván del Moral-Sánchez (ORCID: https://orcid.org/0000-0002-6356-1484)
- Max Crispin (ORCID: https://orcid.org/0000-0002-1072-2694)
- Kalpana Luthra (ORCID: https://orcid.org/0000-0002-7801-2867)
- Swarandeep Singh (ORCID: https://orcid.org/0000-0003-1186-1327)
- Joel D. Allen (ORCID: https://orcid.org/0000-0003-2547-968X)
- Liang Jing (ORCID: https://orcid.org/0000-0003-0194-4022)
- Yog Vaghani
- Rakesh Lodha
- Rogier W. Sanders
Institutions
- Emory University (US)
- Cornell University (US)
- Amsterdam University Medical Centers (NL)
- University of Southampton (GB)
- All India Institute of Medical Sciences (IN)
- University of Amsterdam (NL)
Publication Details
- Journal
- Vaccines
- Published
- 2025-01-22
- DOI
- https://doi.org/10.3390/vaccines13020110
- Citations
- 3
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.11
Funders
- Bill and Melinda Gates Foundation
- International AIDS Vaccine Initiative
- European Molecular Biology Organization
- Emory University
- University of Washington
- Department of Biotechnology, Ministry of Science and Technology, India
- National Institutes of Health